Anita Clayton, MD; John J. Miller, MD; Sanjai Rao, MD, DFAPA; Larry Culpepper, MD; Corine de Boer, MD, PhD; Rif S. El-Mallakh, MD; C. Neill Epperson, MD; Marlene P. Freeman, MD; Nassir Ghaemi, MD, MPH; Joseph F. Goldberg, MD; Benjamin D. Greenberg, MD, PhD; Mark B. Hamner, MD; Brian Hurley, MD, MBA, DFASAM; Alana Iglewicz, MD; Jonathan M. Meyer, MD; Nidal Moukaddam, MD, PhD; Sonya Norman, PhD; Edward Nunes, MD; Dhakshin Ramanathan, MD, PhD; Christopher Schneck, MD; M. Katherine Shear, MD; Michael E. Thase, MD; J. Eric Vance, MD; David B. Yaden, PhD; Rachel Yehuda, PhD; Sidney Zisook, MD

2022 Annual Psychiatric Times™ World CME Conference™ - Day One

2022 Annual Psychiatric Times™ World CME Conference™ - Day Three

2022 Annual Psychiatric Times™ World CME Conference™ - Day Two

Expert Illustrations & Commentaries™: Exploring the Clinical Rationale for Antagonizing Inflammatory IL-1-beta Signaling in NSCLC

Abbey Kaler, MS, APRN, FNP-C; Kelly Leonard, MSN, APRN, FNP-BC

Cases and Conversations™: Nursing Considerations for the Management of ER+ Breast Cancer

Colleen Cotton, MD, FAAD; Raj Chovatiya, MD, PhD, FAAD

Advances in™ Hidradenitis Suppurativa (HS): Optimizing the Management Approach with Available and Emerging Treatments

Robert Z. Orlowski, MD, PhD; Elisabet E. Manasanch, MD, MHSc; Jing Christine Ye, MD, MSc

Charting The Changing Landscape in Multiple Myeloma from Frontline to Relapsed/Refractory Disease

Neil M. Bressler, MD; Jennifer I. Lim, MD, FARVO

(COPE Credit) Community Practice Connections™: Comprehensive Key Advances in Biosimilars for Retinal Diseases – Reviewing the Evidence, Addressing Patient Perspectives, and Practice Utilization for the Retina Specialist

(CME/CNE Credit) Community Practice Connections™: Comprehensive Key Advances in Biosimilars for Retinal Diseases – Reviewing the Evidence, Addressing Patient Perspectives, and Practice Utilization for the Retina Specialist

Neal Shore, MD, FACS; Scott Tagawa, MD, MS, FACP

Expert Illustrations & Commentaries™: The Role of Radioligand Therapy in mCRPC and How It Could Impact Your Practice in the Future

Jennifer Dvorak, MSN, FNP-BC; Beth Sandy, MSN, CRNP

Onco-Nurse Academy™: Exploring an Advent of Targeted Therapies Across Advanced NSCLC Care and Strategies for Managing Adverse Events Associated With Treatment

Arshad M. Khanani MD, MA; Jennifer I. Lim MD, FARVO, FASRS

(COPE Credit) Expert Illustrations & Commentaries™: Visualizing the Angiopoetin-Tie2 Pathway as a Target in Retinal and Choroidal Vascular Diseases

(CME/CNE Credit) Expert Illustrations & Commentaries™: Visualizing the Angiopoetin-Tie2 Pathway as a Target in Retinal and Choroidal Vascular Diseases

Expert Illustrations & Commentaries™: Targeting FGFR2b Overexpression in Advanced Gastric and GEJ Cancers

Elias Jabbour, MD; Hagop M. Kantarjian, MD

Community Practice Connections™: Translating Recent Evidence to the Real-World Management of Acute Lymphoblastic Leukemia

Balazs Halmos, MD, MS; Lynette M. Sholl, MD; Matthew Galsky, MD, FASCO; Kevin Kalinsky, MD, MS; Samuel J. Klempner, MD

Community Practice Connections™: 6th Annual International Congress on Oncology & Pathology™: Towards Harmonization of Pathology and Oncology Standards

Arshad M. Khanani, MD, MA; Peter K. Kaiser, MD; Anat Loewenstein, MD, MHA; Christina Y. Weng, MD, MBA, FASRS

Cases & Conversations™: Inflammation & Pathogenesis in DME – Rethinking the Traditional Treatment Paradigm

Neil M. Bressler, MD; Sophie J. Bakri, MD, MBA; Jennifer I. Lim, MD, FARVO

Comprehensive Key Advances in Biosimilars for Retinal Diseases – Reviewing the Evidence, Addressing Patient Perspectives, and Practice Utilization for the Retina Specialist

Pasi A. Jänne, MD, PhD; Jason Chang, MD; Gregory Riely, MD, PhD; Beth Sandy, MSN, CRNP, OCN 

Clinical Vignettes®: Multidisciplinary Discussions on the Application of Novel EGFR Exon 20 Targeted Regimens for NSCLC Management

Jason J. Luke, MD, FACP; Evan J. Lipson, MD; Yana G. Najjar, MD; Daniel Olson, MD; Sapna Patel, BA, MD

  Medical Crossfire ®: Addressing the Top 10 Clinical Challenges in Melanoma

Ticiana A. Leal, MD; Jordyn P. Higgins, PharmD, BCOP; Ashley Rollins, BSN, OCN

Patient, Provider, and Caregiver Connection™: Shedding a Light on the Patient Journey with KRAS Mutated Lung Cancer

Naval G. Daver, MD ; Guillermo Garcia-Manero, MD ; Uma Borate, MD, MS ; Jacqueline S. Garcia, MD 

Clinical Vignettes: Reshaping Higher-Risk MDS Patient-Centered Care with Emergence of Novel Evidence and Clinical Trials

Joyce O’Shaughnessy, MD; Balazs Halmos, MD, MS; Cathy Eng, MD, FACP, FASCO;  Brian I. Rini, MD, FASCO; Saad Z. Usmani, MD, MBA, FACP; Nilanjan Ghosh, MD, PhD

  Community Practice Connections™: ASCO Direct Highlights: Practice-Changing Data From the Leading Oncology Conference

Mile Brujic, OD, FAAO; Marc R. Bloomenstein, OD, FAAO; Selina McGee, OD, FAAO

(COPE Credit) Community Practice Connections™: Understanding Emerging Options in MGD-Associated Dry Eye Disease—Preparing for an Updated Armamentarium

(CME Credit) Community Practice Connections™: Understanding Emerging Options in MGD-Associated Dry Eye Disease—Preparing for an Updated Armamentarium

Expert Illustrations & Commentaries™: Exploring the Role of Novel Antibody-Drug Conjugates in Advanced NSCLC

Laura S. Wood RN, MSN, OCN; Kathleen D. Burns, MSN, AGACNP-BC, OCN; Michael E Seabright Jr, PharmD, BCOP

Show Me Your Care Plan! Developing Multidisciplinary Strategies to Optimize the First-Line Care of Patients with mRCC

Bradley J. Monk, MD, FACS, FACOG; Bhavana Pothuri, MD, MS; Matthew A. Powell, MD

Community Practice Connections®: How Are We Personalizing Integration of ICIs and Targeted Therapies to Optimize Outcomes in Endometrial Cancer?

BURST Expert Illustrations & Commentaries™: Personalizing Treatment Regimens for Patients with Hemophilia

Broadening the Impact of Adjuvant Immunotherapy in Melanoma 

Elizabeth (Ebbie) Stewart, MD; Hugh Taylor, MD; Homa K. Ahmadzia, MD, MPH; Alyssa Brown, MD; Isabel C. Green, MD; Cynthia Gyamfi-Bannerman, MD, MS; Michael J. Joyner, MD; Amanda N. Kallen, MD, FACOG; Beth Y. Karlan, MD; Heather S. Lipkind, MD, MS; Judette Louis, MD, MPH; JoAnn V. Pinkerton, MD, FACOG, NCMP; Nancy Ringel, MD, MS; Nanette Santoro, MD; Moeun Son, MD, MSCI, FACOG

3rd Annual International Congress on the Future of Women’s Health™

Ophthalmology Consultations™: Keeping an Eye Out for MGD-Associated Dry Eye in Pre/Post-Op Patients – Improving Surgical Outcomes by Optimizing the Surface

Arshad M. Khanani, MD, MA; Anat Loewenstein, MD, MHA

Community Practice Connections™: Inflammation & Pathogenesis in DME – Rethinking the Traditional Treatment Paradigm

Hanny Al-Samkari, MD; Kevin H.M. Kuo, MD, MSc, FRCPC; Sujit Sheth, MD

Medical Crossfire®: Strategies to Manage Transfusional Iron Overload in Patients with ß-hemoglobinopathies: Optimizing Patient Outcomes

Edgardo S. Santos, MD, FACP; Julia Rotow, MD

Advances In™ NSCLC: Exploring CEACAM5 As A New Therapeutic Target

Kenneth C. Anderson, MD; Elias Jabbour, MD; Gilles A. Salles, MD, PhD

Community Practice Connections™: 6th Annual Live Medical Crossfire®: Hematologic Malignancies 

Daniel C. Brennan, MD, FACP; Stanley C. Jordan, MD; Yousuf Kyeso, MD; Bonnie Lonze, MD, PhD

Community Practice Connections™: Expert Approaches to Preventing Graft Failure in Renal Transplant Recipients 

Megan Hinkley, PharmD, BCOP; Meg Taylor, PharmD, CPP

Updates in Therapeutic Strategies for Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach to Optimal Management of Adverse Effects, featuring Counseling Vignettes

Emanuele Zucca, MD; Massimo Federico, MD; Pier Luigi Zinzani, MD, PhD 

Medical Crossfire®: How the Experts Manage Advanced HL and PTCL in the Real World from Frontline to R/R Treatment Settings

Brett King, MD, PhD; Brittany Craiglow, MD

An Animated View of Alopecia Areata to Advance Our Approaches to Patient Management

Cancer Summaries and Commentaries™: Investigating Key Updates for the Treatment and Management of AML and MDS

Follicular Lymphoma Workshop: Forging Patient-Centric Plans With Targeted Therapies Across Lines of Care

22nd Annual International Congress on the Future of Breast Cancer® West

Reflective Case-Based Oncology Collective™: Strategic Algorithms for Challenging Cases in Relapsed/Refractory Multiple Myeloma

Charu Aggarwal, MD, MPH; Dara Aisner, MD, PhD; Balazs Halmos, MD, MS; Julia Kathleen Rotow, MD; David R. Gandara, MD

Community Practice Connections™: Top 10 Oncogenic Markers in NSCLC for 2022: Evolution of Tumor Testing Technologies, Novel Treatments, and Trials!

Scott Tagawa, MD, MS, FACP; Alicia Morgans, MD, MPH; Michael J. Morris, MD

Medical Crossfire®: Key Questions on Sequencing, Radioligands, and Novel Emerging Approaches in CRPC

Narjust Duma, MD; Coral Olazagasti, MD; Gilberto de Lima Lopes, MD, MBA, FASCO; Ana Maria López, MD, MPH, MACP, FRCP;  Vonetta M. Williams, MD, PhD

Working Group™: Strategies for Recognizing and Taking Steps to Address Disparities in Cancer Care Among Diverse Populations

Robert L. Coleman, MD, FACOG, FACS; Ursula A. Matulonis, MD; Bradley J. Monk, MD, FACS, FACOG; Kathleen Moore, MD

Community Practice Connections™: 13th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™

Sara A. Hurvitz, MD, FACP; Aditya Bardia, MD, MPH

Community Practice Connections™: Incorporating Novel HER2-Targeted Therapies Into Treatment Algorithms Across Metastatic Breast Cancer

Jessica Michaud Davis, PharmD, BCOP, CPP; Robert L. Ferris, MD, PhD; Kristi K Orbaugh, MSN, NP, AOCNP

Optimizing Immune Checkpoint Inhibitors in Early-Stage Cancer Treatment Through Multidisciplinary Collaboration

Benjamin P. Levy, MD; David R. Gandara, MD; Aparna R. Parikh, MD, MS; Heather A. Parsons, MD, MPH

Community Practice Connections™:  Analyzing the Evolving Role of Liquid Biopsies Across Cancer Care

Reflective Case-Based Oncology Collective™: Translating Recent Evidence to the Real-World Management of Acute Lymphoblastic Leukemia

24th Annual International Lung Cancer Congress®

Clinical Vignettes™: Testing and Treatment Strategies in Cholangiocarcinoma

2nd Annual Virtual Tumor Board®: Integrating Emerging Testing Methodologies into Optimal Treatment Planning in GI Cancers

James L.M. Ferrara, MD, DSc; Carrie L. Kitko, MD

Community Practice Connections™: Incorporating Novel Therapies Into Treatment Algorithms Across Acute and Chronic GVHD

Advanced Renal Cell Carcinoma: Tyrosine Kinase Inhibitors Versus Immune Checkpoint Inhibitors

Sandra Kurtin, PhD, ANP-BC, AOCN; Ravi Vij, MD, MBA; Kathryn Maples, PharmD, BCOP

Advances In: Interprofessional Strategies to Optimize Outcomes for Patients with Relapsed/Refractory Multiple Myeloma: Expert Discussions to Maximize Safety and Efficacy

Virtual Testing Board: Digging Deeper on Your Testing Reports to Elevate Patient Outcomes in Advanced Non–Small Cell Lung Cancer

Clement L. Ren, MD, MBA, ATSF; Samya Nasr, MD, CPI, ATSF; George M. Solomon, MD

Clinical Consultations™: Optimizing Treatment Outcomes for Patients With Cystic Fibrosis

BURST CME™: Exploring the Biologic Rationale for Novel IRAK4-directed Therapy for the Treatment of High Risk MDS and AML 

Bradley J. Monk, MD, FACS, FACOG; Lucy Gilbert, MD, MSc, FRCOG; Bhavana Pothuri, MD, MS; Matthew A. Powell, MD

Medical Crossfire®: How Are We Personalizing Integration of ICIs and Targeted Therapies to Optimize Outcomes in Endometrial Cancer?

4th Annual Virtual Tumor Board®: Diagnosis and Management of Polycythemia Vera and Myelofibrosis

Jeff Unger, MD, FAAFP, FACE;  Jennifer D. Goldman, PharmD, RPh, CDCES, BC-ADM, FCCP; Carrie McAdam-Marx, PhD, RPh; Brittany Hoffmann-Eubanks, PharmD, MBA; Angel A. Rodriguez, PharmD; Lori A. Uildriks, PharmD, BCPS, BCGP; Jeannette Y. Wick, RPh, MBA, FASCP

Analyzing the Value of Continuous Glucose Monitoring in Diabetes Care and Overcoming Barriers Through Expanded Pharmacy Access

Virtual Show Me the Data™: How HER2, HER3, and TROP2 Targeted Strategies Will Impact Evolving Paradigms in NSCLC

Caring for Patients on CAR T-Cell Therapy in the Inpatient Versus Outpatient Setting

Advances In™: The Role of NRG1 Fusions Across Tumor Types

Tiffany A. Traina, MD; Odessa Williams, AGPCNP-BC; Latasha Jordan; Nicole Badgett

Patient, Provider, and Caregiver Connection™: Addressing Patient Concerns During the Treatment and Management of TNBC

Terry P. Mamounas, MD, MPH, FACS; Joyce O’Shaughnessy, MD; David M. Euhus, MD, FACS

Community Practice Connections™: Navigating Adjuvant Decision-Making for High-Risk Early-Stage Hormone Receptor-Positive Breast Cancer

Christopher R. Flowers, MD, MS, FASCO; Frederick L. Locke, MD; Kami J. Maddocks, MD; Laurie H. Sehn MD, MPH

Hot Seat™: Expert Considerations to Maximize the Clinical Benefits of Targeted Therapies in Patients With Relapsed/Refractory DLBCL

Aditya Bardia, MD, MPH; Erika P. Hamilton, MD; Komal Jhaveri, MD, FACP; Nicholas Turner, MD, PhD 

  Medical Crossfire®: Evaluating the Potential Role of Next-Generation Selective Estrogen Receptor Degraders in the ER+/HER2- Breast Cancer Treatment Paradigm

Jonathan I. Silverberg, MD, PhD, MPH, FAAD; Peck Y. Ong, MD


Individualizing Treatment in Moderate-to-Severe Atopic Dermatitis through Improved Clinician-Patient Communication

Edward B. Garon, MD, MS; Lyudmila Bazhenova, MD; Solange Peters, MD, PhD; Zofia Piotrowska, MD, MHS

Medical Crossfire®: Leveraging EGFR Mutation Profiles to Personalize Therapeutic Decisions in Resected and Metastatic NSCLC Settings

Ruben A. Mesa, MD, FACP ; Jamile M. Shammo, MD, FASCP, FACP ; Naveen Pemmaraju, MD 

Expert Illustrations and Commentaries™: Placing New MPN Therapies Into Context Through Illustrated Case Discussions

Robert Dreicer, MD, MS, MACP, FASCO; Tomasz Beer, MD, FACP; Scott Tagawa, MD, MS, FACP; Tanya Dorff, MD

How Guidelines and Recent Clinical Trial Data Inform the Modern-Day Treatment of Advanced Prostate Cancer

Dawn A. Laney, MS, CGC; Eric Wallace, MD, FASN

Clinical ConsultationsTM: Focusing on Fabry Disease in Females: Individualizing Diagnostic and Counseling Plans to Improve Long-Term Outcomes

Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Leah Smith, MSN, APRN, FNP-BC, CNN-NP, FNKF; Catherine Wells, DNP, ACNP, CNN-NP, FNKF

Cases and Conversations: Individualizing Diabetes Care in the Management of Chronic Kidney Disease: Developing the Optimal Treatment Plan With Your Patient

John Rhodes, MD; Robert J. Sommer, MD; Christine A. Holmstedt, DO

Medical Crossfire: Optimizing Outcomes for Patients with Stroke: Secondary Prevention and Risk Reduction

Susanna V Ulahannan, MD, MMEd; Manish Patel, MD


Expert Illustrations & Commentaries™: The Role of B7-H3 Across Tumor Types and How It Could Impact Your Practice in the Future

Jeffrey Laurence, MD; Mitchell S. Cairo, MD; Vincent T. Ho, MD; Sonata Jodele, MD

New Perspectives in HSCT-TMA: Driving the Future of Diagnosis and Treatment

Luciano J. Costa, MD, PhD; Paul Shaughnessy, MD

Optimizing ASCT in Patients With Multiple Myeloma and Non-Hodgkin Lymphoma Through Stem Cell Mobilization Techniques

Anita Afzali, MD, MPH, MHCM; Marla C. Dubinsky, MD; Christina Ha, MD, FACG, AGAF

Optimizing Care in Inflammatory Bowel Disease (IBD): The Role of Emerging Therapies in Improving Patient Outcomes

Jane S. Davis, CRNP, DNP; Jean Colaneri, ACNP-BC, CNN-NP

Community Practice Connections™: Expert Illustrations and Commentaries: Nephrology Nurse Perspectives in Anemia in CKD

Genovefa Papanicolaou, MD; Guenther Koehne, MD, PhD; Roy F. Chemaly, MD, MPH, FIDSA, FACP; Sanjeet Dadwal, MD, FACP, FIDSA

Community Practice Connections™: Evolving Paradigms in Transplant-Related CMV Prevention and Management: Setting Foundations for Improved Patient Outcomes

CAR T-Cell Therapy in Multiple Myeloma: Key Considerations for Patient Selection, Transplant, and Applying Recent Data

Evolving Paradigms in Transplant-Related CMV Prevention and Management: Setting Foundations for Improved Patient Outcomes

Burst CME: Improving Outcomes for Your Patient with Vitiligo

Elizabeth Verna, MD, MSc; Arun B. Jesudian, MD

Clinical Consultations™: Facilitating Optimal Treatment Outcomes and Multidisciplinary Care in Hepatorenal Syndrome- Acute Kidney Injury (HRS-AKI)

Burst Expert Illustrations & Commentaries™: Management Strategies for Refractory Ascites

Elizabeth Verna, MD, MSc; Lisa B. VanWagner, MD, MSc, FAST, FAHA

Advances In™ Cirrhosis: Reframing the Management of Hepatorenal Syndrome-Acute Kidney Injury: A Review of Current Strategies

Burst Expert Illustrations & Commentaries™: Current Treatments for Esophageal Variceal Hemorrhage

The 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™

Matthew Lunning, DO, FACP; Yi Lin, MD, PhD

Community Practice Connections™: Translating Recent Evidence on CAR T-Cell Therapy to the Real-World Management of Lymphoid Malignancies

Corey S. Cutler, MD, MPH; Catherine Lee, MD

Expert Illustrations & Commentaries™: Exploring the Rationale for Emerging Mechanistic Approaches in cGvHD

Fátima Cardoso, MD; Mario Campone, MD, PhD; Giuseppe Viale, MD, FRCPath

Tumor Board: How The Experts Approach Personalized Care Plans in ER-Positive Breast Cancer

Charu Aggarwal, MD, MPH; Dara Aisner MD, PhD; D. Ross Camidge, MD, PhD; Balazs Halmos, MD, MS; Julia Kathleen Rotow, MD

Top 10 Oncogenic Markers in NSCLC for 2022: Evolution of Tumor Testing Technologies, Novel Treatments, and Trials!

Krishna Komanduri, MD; Juan Ramirez, APRN-BC; Charalambos Andreadis, MD; Laura J. Zitella, NP, MSN

Continuing Education

Latest News